TITLE

Reply

AUTHOR(S)
Tedadli, Ellen M.; Baker, Rose
PUB. DATE
August 2003
SOURCE
Clinical Infectious Diseases;8/1/2003, Vol. 37 Issue 3, p461
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Responds to comments about the authors' article on how the HIV-HCV-coinfected group in their analysis had lower CD4 cell counts and a shorter observation time than the HIV-monoinfected cohort. Dynamics of viral coinfection as it impacts decline in CD4 cell counts; Certainty that other mortality analyses for HIV-HCV coinfection will continue to be performed.
ACCESSION #
10590273

 

Related Articles

  • The Influence of Portal Pressure on the Discordance Between Absolute CD4+ Cell Count and CD4+ Cell Percentage in HIV/Hepatitis C Virus–Coinfected Patients. Mandorfer, M.; Reiberger, T.; Payer, B. A.; Peck-Radosavljevic, M. // Clinical Infectious Diseases;Mar2013, Vol. 56 Issue 6, p904 

    A letter to the editor is presented in response to two articles including "Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus" by M. W. Hull and colleagues and "Discordance between CD4+ T-lymphocyte...

  • Reply to Mandorfer et al. Hull, Mark W.; Rollet, Kathleen; Klein, Marina B. // Clinical Infectious Diseases;Mar2013, Vol. 56 Issue 6, p905 

    A response from the author of the article "Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus" in the 2012 issue is presented.

  • Hepatitis C Infection Influence on Immune Recovery in HIV-Positive Patients on Successful HAART: The Role of Genotype 3. Seminari, Elena; Tinelli, Carmine; Ravasi, Giovanni; Ripamonti, Diego; Ladisa, Nicoletta; Marino, Nicoletta; Sighinolfi, Laura; Mondello, Placido; Migliorino, Marco; Carosi, Giampiero; Maserati, Renato // Current HIV Research;Apr2010, Vol. 8 Issue 3, p186 

    Objective: The primary objective of this study was to investigate the impact of HCV infection and of HCV genotypes on immune restoration in HIV-infected patients on a successful HAART regimen. Methods: Patients from the MASTER Study were included in this current longitudinal study if they met...

  • Diminished frequency of hepatitis C virus specific interferon γ secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients. Harcourt, G.; Gomperts, E.; Donfield, S.; Klenerman, P. // Gut;Oct2006, Vol. 55 Issue 10, p1484 

    Background: Human immunodeficiency virus/hepatitis C virus (HIV/HCV) coinfection is a common and complex clinical problem in which loss of immunological control of HCV occurs, with increased HCV viral load and more aggressive liver disease. Cellular immune responses, particularly secretion of...

  • Can HCV affect the efficacy of anti-HIV treatment? Filippini, P.; Coppola, N.; Scolastico, C.; Liorre, G.; Nocera, R.; Sagnelli, E.; Piccinino, F. // Archives of Virology;May2000, Vol. 145 Issue 5, p937 

    Summary. To evaluate the impact of new antiretroviral combinations (HAART: Highly Active Anti Retroviral Therapy) on HCV replication and liver enzyme levels, we analysed the changes in HCV viremia and aminotransferase levels in HIV and HCV co-infected patients. Moreover, to evaluate the...

  • Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Finzi, Diana; Blankson, Joel; Siliciano, Janet D.; Margolick, Joseph B.; Chadwick, Karen; Pierson, Theodore; Smith, Kendall; Lisziewicz, Julianna; Lori, Franco; Flexner, Charles; Quinn, Thomas C.; Chaisson, Richard E.; Rosenberg, Eric; Walker, Bruce; Gange, Stephen; Gallant, Joel; Siliciano, Robert F. // Nature Medicine;May99, Vol. 5 Issue 5, p512 

    Combination therapy for HIV-1 infection can reduce plasma virus to undetectable levels, indicating that prolonged treatment might eradicate the infection. However, HIV-1 can persist in a latent form in resting CD4[sup +] T cells. We measured the decay rate of this latent reservoir in 34 treated...

  • Effects of Virologic Rebound on CD4 Cell Counts. Bahrani, Ashkan; Ramaswamy, Ramesh; Oldfield III, Edward C. // Clinical Infectious Diseases;4/15/2001, Vol. 32 Issue 8, p1231 

    Presents information on a study which examined the effects of virologic rebound on CD4 cell counts in HIV-infected patients. Methodology; Results of the study; Discussion.

  • Is the clinical course of HIV-1 changing? Cohort study. Sinicco, A.; Fora, R. // BMJ: British Medical Journal (International Edition);04/26/97, Vol. 314 Issue 7089, p1232 

    Assesses whether the clinical course of HIV infection has changed from 1985 to 1995. Disease progression; Speed of CD4 cell decline in patients with recently acquired HIV infection.

  • HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Pitcher, Christine J.; Quittner, Claudia; Peterson, Dolores M.; Connors, Mark; Koup, Richard A.; Maino, Vernon C.; Picker, Louis J. // Nature Medicine;May99, Vol. 5 Issue 5, p518 

    The role of HIV-1-specific CD4[sup +] T-cell responses in controlling HIV-1 infection remains unclear. Previous work has suggested that such cells are eliminated in the early stages of infection in most subjects, and thus cannot substantially contribute to host defense against HIV-1. Here, using...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics